 suppress chronic myelogen leukemia coloni growth receptor antagonist solubl receptor novel applic inhibitor activ studi role beta beta malign evolut chronic myelogen leukemia cml function activ inhibitor bone marrow BM peripher blood PB low-dens cell cml patient colony-form unit-granulocyt erythrocyt monocyt megakaryocyt coloni cultur sampl patient earli stage interferon-alpha ifn -sensit diseas hematopoiet coloni presenc fetal calf serum fc epo follow granulocyte-macrophag colony-stimul factor ng/ml ng/ml phytohemagglutinin-condit medium addit beta ifn-sensit cml coloni growth dose-depend manner concentr u/ml sharp contrast addit growth factor coloni growth-promot effect fc epo sampl ifn-resist patient adher cell fraction t-lymphocyt deplet autonom coloni growth lysat low-dens cell ifn-resist ifn-sensit cml patient normal volunt intrins beta content enzyme-link immunosorb assay mean pg pg pg beta solubl receptor receptor antagonist concentr ng/ml ng/ml cml coloni growth dose-depend fashion maxim inhibit similar effect use beta antibodi data beta cml diseas progress inhibitori effect molecul basi novel therapeut strategi disord